Daniel Arias

Stock Analyst at Stifel

(5.00)
# 10
Out of 5,140 analysts
169
Total ratings
56.7%
Success rate
139.61%
Average return

Stocks Rated by Daniel Arias

Guardant Health
Feb 20, 2026
Maintains: Buy
Price Target: $120$130
Current: $103.10
Upside: +26.09%
10x Genomics
Feb 13, 2026
Maintains: Buy
Price Target: $15$20
Current: $18.88
Upside: +5.93%
Qiagen
Feb 6, 2026
Maintains: Hold
Price Target: $45$50
Current: $48.57
Upside: +2.94%
Bio-Techne
Feb 5, 2026
Maintains: Hold
Price Target: $60$65
Current: $57.52
Upside: +13.00%
Illumina
Jan 20, 2026
Maintains: Buy
Price Target: $135$155
Current: $117.67
Upside: +31.72%
Thermo Fisher Scientific
Jan 9, 2026
Maintains: Buy
Price Target: $583$700
Current: $510.93
Upside: +37.01%
BillionToOne
Dec 1, 2025
Initiates: Buy
Price Target: $145
Current: $85.42
Upside: +69.75%
Exact Sciences
Nov 28, 2025
Downgrades: Hold
Price Target: $80$105
Current: $103.43
Upside: +1.52%
Mettler-Toledo International
Nov 10, 2025
Maintains: Buy
Price Target: $1,450$1,600
Current: $1,377.55
Upside: +16.15%
Bruker
Aug 5, 2025
Maintains: Hold
Price Target: $48$40
Current: $38.28
Upside: +4.49%
Maintains: Hold
Price Target: $14$12
Current: $9.03
Upside: +32.89%
Maintains: Hold
Price Target: $120$110
Current: $100.33
Upside: +9.64%
Upgrades: Buy
Price Target: $260
Current: $209.50
Upside: +24.11%
Maintains: Buy
Price Target: $11$9
Current: $0.74
Upside: +1,117.20%
Maintains: Buy
Price Target: $17$6
Current: $6.67
Upside: -10.04%
Downgrades: Hold
Price Target: $45$65
Current: $58.37
Upside: +11.36%
Maintains: Hold
Price Target: $332$360
Current: $333.33
Upside: +8.00%
Maintains: Buy
Price Target: $163$151
Current: $122.90
Upside: +22.86%
Maintains: Buy
Price Target: $11$10
Current: $3.10
Upside: +222.58%
Maintains: Buy
Price Target: $165$207
Current: $135.68
Upside: +52.56%
Maintains: Buy
Price Target: $9$5
Current: $1.17
Upside: +327.35%
Maintains: Hold
Price Target: $28$10
Current: $2.65
Upside: +277.36%